300 - Clinical Experience with 16S Ribosomal RNA Gene PCR and Sequencing of Normally Sterile Body Fluids and Tissues in Pediatric Patients

Friday, October 18, 2024

10:54 AM – 11:06 AM US PT

Location: 411

Presenting Author(s)

Guyu Li, M.B.B.S. (he/him/his)

Fellow Physician, Assistant professor
Mayo Clinic
Rochester, Minnesota, United States

Slides

Co-Author(s)

Christopher Reis, MD (he/him/his)

Pediatric Infectious Diseases Fellow
Mayo Clinic
Rochester, Minnesota, United States
RK

Rebecca M. Kruc, M.D., M.P.H.

Mayo Clinic
Rochester, Minnesota, United States
NS

Nicholas Streck, PhD, MLS(ASCP)

Mayo Clinic
Rochester, Minnesota, United States
Elizabeth H. Ristagno, MD, MSc (she/her/hers)

Dr.
Mayo Clinic
Rochester, MN, United States
ZZ

Ziyuan Zhang, B.A.

Harvard T.H. Chan School of Public Health
Boston, Massachusetts, United States
MW

Matthew Wolf, MS

Mayo Clinic
Rochester, Minnesota, United States
JG

James Gaensbauer, MD, MScPH

Mayo Clinic
Rochester, Minnesota, United States
Robin Patel, MD (she/her/hers)

Professor
Mayo Clinic
Rochester, MN, United States

Disclosure(s):

Guyu Li, M.B.B.S.: No financial relationships to disclose

Christopher Reis, MD: No financial relationships to disclose

Rebecca M. Kruc, M.D., M.P.H.: No financial relationships to disclose

Nicholas Streck, PhD, MLS(ASCP): No financial relationships to disclose

Ziyuan Zhang, B.A.: No financial relationships to disclose

Matthew Wolf, MS: No financial relationships to disclose

James Gaensbauer, MD, MScPH: No financial relationships to disclose

Robin Patel, MD: a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, a: See above; MicuRx Pharmaceuticals and BIOFIRE: Grant/Research Support; PhAST, Day Zero Diagnostics, Abbott Laboratories, Sysmex, DEEPULL DIAGNOSTICS, S.L., Netflix, Oxford Nanopore Technologies and CARB-X: Advisor/Consultant; Up-to-Date and the Infectious Diseases Board Review Course.: Honoraria